Epirubicin Interventional Chemotherapy for Sinonasal Adenoid Cystic Carcinoma (SNACC): A Prospective Study

NCT07320508 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Adenoid Cystic Carcinoma
Sinonasal Carcinoma
Epirubicin

Interventions

DRUG: Epirubicin (E)

Sponsor

Eye & ENT Hospital of Fudan University